
Blood cannot clot normally in people with haemophilia, a genetic disorder. People who have haemophilia lack or do not have a certain protein in their blood that aids in blood clotting. They consequently tend to bleed more frequently than usual or extremely easily. According to which protein is absent, there are 2 primary forms of haemophilia (designated "A" and "B"): Deficiencies in factors VIII and XI are associated with haemophilia A and B, respectively. Knowing if you have haemophilia A or B is crucial since your course of therapy will change.
A genetic disorder
Hemophilia is an inherited condition passed on from a parent to their children. The genes for producing factor VIII and Factor XI are on chromosome X. Since males have only one X chromosome, they are more likely to develop severe symptoms from haemophilia than females. Females either have mild or no symptoms but can be silent carriers of this condition.
Also Read: How can obesity cause NAFLD? Can an untreated NAFLD lead to Liver cancer?
Common symptoms and complications:
Based on the clotting factor in the blood, Hemophilia is categorized as mild, moderate or severe. Knowing this information helps the doctor predict complications and advise the patient on care and treatment. Some common issues faced by haemophilia patients include:
Treatment
How severe a person's haemophilia is will determine how they are treated. Additionally, it depends on whether the patient will undergo a procedure or surgery.
Factor replacement therapy: This gives the body what it lacks regarding clotting factor. There are two ways to employ replacement therapy:
Emiczumab - This is a medication that works by mimicking the action of factor VIII and bypasses the need for Factor VIII replacement therapy. It is also useful in patients who develop inhibitors to factor VIII. While it is available in India, cost is a prohibitory factor in its use.
Also Read: Here are four summer beverages to keep your kids active and healthy
Inhibitors in Hemophilia Patients: Some patients develop “inhibitors” in their blood, which interfere with clotting factor replacement therapy. These inhibitors prevent the clotting factor from working properly. This can make it more difficult to control bleeding, as higher doses of clotting factor may be required to overcome the inhibitory effect. This can result in more frequent and severe bleeding episodes, increasing the risk of complications such as joint damage and infections. Managing this can be challenging and requires specialized care from health care providers experienced in the treatment of this condition.
Hemophilia in India:
It is rare in India, and it is estimated that around 20000 people are living with the condition in the country. Unfortunately, many people with Hemophilia in India face significant challenges in adequate treatment and care. Several factors contribute to this, including a lack of awareness and understanding of the condition among health care providers, limited access to appropriate diagnostic and treatment facilities and high treatment costs. As a result, many people with haemophilia in India do not receive the care they need, which can lead to significant health problems.
Living with Hemophilia
Living with hemophilia can be challenging, but with proper care and management, individuals with the condition can lead normal and active lives. Some important aspects to consider are:
Explore the latest Lifestyle News covering fashion, wellness, travel, Food and Recipes, and more. Stay updated with trending Health News, fitness tips, and expert insights to inspire your daily living. Discover personalized lifestyle trends that keep you stylish and informed. Download the Asianet News Official App from the Android Play Store and iPhone App Store for everything that adds value to your everyday life.